Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the...
IQVIA Institute Report Reveals Significant Growth in Funding, Productivity, and Product Launches within the Global Biopharma R&D Sector in 2023
The biopharmaceutical research and development...
BOSTON–(BUSINESS WIRE)– #ANXIETY–Quolet, a private clinical stage biopharmaceutical company, is announcing the completion of a Phase 1 healthy volunteer study evaluating pure Cannabidiol (CBD)...
Companies to automate a critical step of high-throughput single-cell multiomics experiments
FRANKLIN LAKES, N.J., Jan. 23, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:...
NEW FILINGS
Company: Kyverna Therapeutcs, Inc.
Symbol: KYTX (Nasdaq)
Description: They are a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune...
Terms Added
Company: Palmer Square Capital BDC Inc.
Symbol: PSBD
Description: Palmer Square is an externally managed, non-diversified closed-end management investment company that primarily lends to and...